HK1112918A1 - Benzofuranyl derivatives as 5-ht6-receptor inhibitors - Google Patents
Benzofuranyl derivatives as 5-ht6-receptor inhibitorsInfo
- Publication number
- HK1112918A1 HK1112918A1 HK08108312.6A HK08108312A HK1112918A1 HK 1112918 A1 HK1112918 A1 HK 1112918A1 HK 08108312 A HK08108312 A HK 08108312A HK 1112918 A1 HK1112918 A1 HK 1112918A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- receptor inhibitors
- benzofuranyl derivatives
- benzofuranyl
- derivatives
- inhibitors
- Prior art date
Links
- 108091005435 5-HT6 receptors Proteins 0.000 title 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0501383 | 2005-06-17 | ||
US70652305P | 2005-08-09 | 2005-08-09 | |
PCT/EP2006/063249 WO2006134150A1 (en) | 2005-06-17 | 2006-06-15 | Benzofuranyl derivatives as 5-ht6-receptor inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1112918A1 true HK1112918A1 (en) | 2008-09-19 |
Family
ID=36659956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08108312.6A HK1112918A1 (en) | 2005-06-17 | 2008-07-28 | Benzofuranyl derivatives as 5-ht6-receptor inhibitors |
Country Status (19)
Country | Link |
---|---|
US (1) | US7582767B2 (xx) |
EP (1) | EP1896460B1 (xx) |
JP (1) | JP2008543813A (xx) |
KR (1) | KR20080017482A (xx) |
CN (1) | CN101193885B (xx) |
AU (1) | AU2006259082B2 (xx) |
BR (1) | BRPI0612746A2 (xx) |
CA (1) | CA2610383A1 (xx) |
DE (1) | DE602006008002D1 (xx) |
DK (1) | DK1896460T3 (xx) |
EA (1) | EA015671B1 (xx) |
ES (1) | ES2330145T3 (xx) |
HK (1) | HK1112918A1 (xx) |
IL (1) | IL187575A (xx) |
MX (1) | MX2007015988A (xx) |
NO (1) | NO20080354L (xx) |
NZ (1) | NZ563510A (xx) |
WO (1) | WO2006134150A1 (xx) |
ZA (1) | ZA200710468B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0303480D0 (sv) * | 2003-12-19 | 2003-12-19 | Biovitrum Ab | Benzofuranes |
WO2014013014A1 (en) | 2012-07-18 | 2014-01-23 | Fundació Privada Centre De Regulació Genòmica (Crg) | Jak inhibitors for activation of epidermal stem cell populations |
CN103880797B (zh) * | 2014-03-26 | 2015-12-02 | 沈阳大学 | 苯并呋喃类化合物及其医药用途 |
WO2018041989A1 (en) | 2016-09-02 | 2018-03-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating refractory celiac disease type 2 |
WO2020201362A2 (en) | 2019-04-02 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
WO2020212395A1 (en) | 2019-04-16 | 2020-10-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of jak inhibitors for the treatment of painful conditions involving nav1.7 channels |
WO2023222565A1 (en) | 2022-05-16 | 2023-11-23 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
WO2000034242A1 (en) | 1998-12-11 | 2000-06-15 | Virginia Commonwealth University | Selective 5-ht6 receptor ligands |
US7144883B2 (en) | 2001-06-11 | 2006-12-05 | Biovitrum Ab | Bicyclic sulfonamide compounds |
RS44204A (xx) * | 2001-11-22 | 2007-06-04 | Biovitrum Ab., | Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1 |
JP4754821B2 (ja) * | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ii型糖尿病およびcns障害の治療に有用な新規化合物 |
SG156524A1 (en) | 2002-06-20 | 2009-11-26 | Biovitrum Ab Publ | New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
SE0303480D0 (sv) * | 2003-12-19 | 2003-12-19 | Biovitrum Ab | Benzofuranes |
-
2006
- 2006-06-05 US US11/447,524 patent/US7582767B2/en not_active Expired - Fee Related
- 2006-06-15 NZ NZ563510A patent/NZ563510A/en not_active IP Right Cessation
- 2006-06-15 CA CA002610383A patent/CA2610383A1/en not_active Abandoned
- 2006-06-15 BR BRPI0612746-0A patent/BRPI0612746A2/pt not_active IP Right Cessation
- 2006-06-15 KR KR1020087001242A patent/KR20080017482A/ko not_active Application Discontinuation
- 2006-06-15 DE DE602006008002T patent/DE602006008002D1/de active Active
- 2006-06-15 DK DK06763743T patent/DK1896460T3/da active
- 2006-06-15 EA EA200800071A patent/EA015671B1/ru not_active IP Right Cessation
- 2006-06-15 AU AU2006259082A patent/AU2006259082B2/en not_active Ceased
- 2006-06-15 ES ES06763743T patent/ES2330145T3/es active Active
- 2006-06-15 MX MX2007015988A patent/MX2007015988A/es active IP Right Grant
- 2006-06-15 WO PCT/EP2006/063249 patent/WO2006134150A1/en active Application Filing
- 2006-06-15 ZA ZA200710468A patent/ZA200710468B/xx unknown
- 2006-06-15 CN CN2006800201432A patent/CN101193885B/zh not_active Expired - Fee Related
- 2006-06-15 EP EP06763743A patent/EP1896460B1/en not_active Not-in-force
- 2006-06-15 JP JP2008516325A patent/JP2008543813A/ja not_active Withdrawn
-
2007
- 2007-11-22 IL IL187575A patent/IL187575A/en not_active IP Right Cessation
-
2008
- 2008-01-17 NO NO20080354A patent/NO20080354L/no not_active Application Discontinuation
- 2008-07-28 HK HK08108312.6A patent/HK1112918A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA015671B1 (ru) | 2011-10-31 |
US20060293361A1 (en) | 2006-12-28 |
EA200800071A1 (ru) | 2008-10-30 |
NZ563510A (en) | 2011-01-28 |
CN101193885A (zh) | 2008-06-04 |
ZA200710468B (en) | 2009-04-29 |
AU2006259082A1 (en) | 2006-12-21 |
US7582767B2 (en) | 2009-09-01 |
CN101193885B (zh) | 2011-07-27 |
IL187575A (en) | 2012-12-31 |
AU2006259082B2 (en) | 2011-07-14 |
IL187575A0 (en) | 2008-03-20 |
ES2330145T3 (es) | 2009-12-04 |
MX2007015988A (es) | 2008-03-07 |
BRPI0612746A2 (pt) | 2010-11-30 |
EP1896460B1 (en) | 2009-07-22 |
DK1896460T3 (da) | 2009-11-16 |
DE602006008002D1 (de) | 2009-09-03 |
CA2610383A1 (en) | 2006-12-21 |
NO20080354L (no) | 2008-01-17 |
WO2006134150A1 (en) | 2006-12-21 |
EP1896460A1 (en) | 2008-03-12 |
KR20080017482A (ko) | 2008-02-26 |
JP2008543813A (ja) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI370127B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
ZA200707650B (en) | Azolylacylguanidines as ß-secretase inhibitors | |
ZA200806148B (en) | 2-adamantylurea derivatives as selective 11ß-HSD1 inhibitors | |
HK1129305A1 (zh) | 取代的 -氨基-吡咯並三嗪衍生物 | |
HK1114380A1 (en) | Pyrrolopyrazoles as kinase inhibitors | |
ZA200700181B (en) | Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors | |
ZA200702394B (en) | Indozolone derivatives as 11b-HSD1 inhibitors | |
HUS2000022I1 (hu) | Tiglien-3-on származékok | |
ZA200710951B (en) | Piperidinyl-substituted isoquinolone derivatives as Rhokinase inhibitors | |
EP1878727A4 (en) | 2-AMINOQUINAZOLINE DERIVATIVES | |
IL192092A0 (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
IL185674A0 (en) | 1-benzylindole-2-carboxamide derivatives | |
ZA200809800B (en) | 2-Thioxanthine derivatives acting as Mpo-inhibitors | |
IL184841A0 (en) | Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives | |
IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
HK1112918A1 (en) | Benzofuranyl derivatives as 5-ht6-receptor inhibitors | |
IL191138A0 (en) | Pyrazoloisoquinoline derivatives | |
ZA200800672B (en) | Introcatechol derivatives as COMT inhibitors | |
GB0511410D0 (en) | Benzotrizepinone derivatives | |
GB0614154D0 (en) | Novel Pyriazine Derivatives | |
GB0516967D0 (en) | Inhibitors | |
ZA200706212B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
GB0514579D0 (en) | Substituted benzyloxy-phenylmethylamide derivatives | |
GB0506443D0 (en) | Novel inhibitors | |
GB0500900D0 (en) | Azaquinazoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150615 |